new glp-1 drugs Guidelines for Type 2 Diabetes in 2025 GLP-1 analogs, new trend in
Description
As GLP-1 therapies such as Semaglutide and Tirzepatide move beyond diabetes management into mainstream obesity treatment, the scale of adoption is unprecedented in India
Doustdar thinks the program could be an opportunity to regain some of the ground Novo's Wegovy shot has lost to Lilly's Zepbound
Endocrinology, 8
i , Quantification of cFOS + cells in rostral linear nucleus raphe (RR)
Takeda S, Sato N, Uchio-Yamada K, et al
Severe Side Effects Claimed in Ozempic Lawsuits NAION Blindess Vision Loss Gastroparesis Ileus Intestinal obstruction Intestinal pseudo-obstruction Other gastrointestinal injuries There is no cure for NAION or gastroparesis
